Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Authors:
- Stephan PommierSPStephan Pommier
- Franck MeyerFMFranck Meyer
- Christian HajjarCHChristian Hajjar
- Pierre Yves MeritePMPierre Yves Merite
- Eric ParratEPEric Parrat
- Herve RouhetteHRHerve Rouhette
- Olivier RebolloOROlivier Rebollo
- Frederic MatontiFMFrederic Matonti
- 22 April 2015
- journal article
- research article
- Published by S. Karger AG in Ophthalmologica
- Vol. 233 (3-4) , 169-175
Abstract
Purpose: To evaluate the efficacy and safety of intravitreal implant of dexamethasone (Ozurdex®) in diabetic macular edema (DME). Methods: This was a retrospective multicenter noncomparative study. Seventy-eight patients with DME followed for at least 6 months were included (P1.5 Network). Best-corrected visual acuity (BCVA), central retinal thickness (CRT), intraocular pressure (IOP) and cataract progression were studied at baseline and then at 1, 2, 4 and 6 months. Results: The mean CRT decrease from baseline was 145.2 µm at 6 months. The mean BCVA improvement from baseline was 6.7 at 6 months. An increase in IOP was observed for 11.7% of patients, and all patients were managed by topical treatment. No glaucoma or cataract surgery was necessary, and no endophthalmitis was reported. Conclusions: One injection of Ozurdex has an anatomical and functional effectiveness for the treatment of DME. Side effects were rare and manageable in our practice.Keywords
This publication has 17 references indexed in Scilit:
- Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practiceActa Ophthalmologica, 2013
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationOphthalmology, 2012
- Intravitreal Dexamethasone Implant in Patients with Persistent Diabetic Macular EdemaOphthalmologica, 2012
- The RESTORE StudyOphthalmology, 2011
- Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular EdemaOphthalmology, 2011
- On the retinal toxicity of intraocular glucocorticoidsBiochemical Pharmacology, 2010
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Randomized Controlled Trial of an Intravitreous Dexamethasone Drug Delivery System in Patients With Diabetic Macular EdemaArchives of Ophthalmology (1950), 2010
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993